#news #biotech Harvard’s Kesselheim quits AdComm over FDA’s Aduhelm approval

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Harvard’s Kesselheim quits AdComm over FDA’s Aduhelm approval .Harvard’s Kesselheim quits AdComm over FDA’s Aduhelm approval
ntaylor
Fri, 06/11/2021 – 04:52

from FierceBiotech: Biotech https://ift.tt/3zjl3mW